Schematic illustration depicting the potential anti-inflammatory effects of hypolipidemic agents primarily targeting LDL-C reduction
Schematic illustration depicting the potential anti-inflammatory effects of hypolipidemic agents primarily targeting LDL-C reduction. (A). Typically, HMGCR facilitates the activation of TLRs, which subsequently triggers the expression of inflammasome-related genes through the NF-kB signaling pathway. This leads to inflammasome formation and the activation of caspase-1 protein, resulting in the maturation of several pro-inflammatory cytokines, including TNF-a. TNF-a promotes the adhesion of various molecules, such as VCAM-1 and E-selectin, contributing to endothelial dysfunction. Statins may exert anti-inflammatory effects either by inhibiting HMGCR or by enhancing the expression of PXR, a receptor commonly found in the vasculature. Activation of PXR reduces the expression of these adhesion molecules, thus promoting vascular detoxification and reducing vascular inflammation. (B). PCSK9 increases the expression of VEGF-A and ICAM-1 adhesion molecules, which leads to the migration of monocytes and macrophages, thereby boosting the production of pro-inflammatory cytokines and causing endothelial dysfunction. Silencing PCSK9 may counteract these effects. (C). Bempedoic acid exerts its anti-inflammatory effects primarily by upregulating AMPK, which subsequently reduces the activation of MAPK pro-inflammatory pathways. Additionally, bempedoic acid may improve the inflammatory environment by decreasing the production of prostaglandin E2 through the inhibition of ACLY. Abbreviations: ACLY, ATP-citrate lyase; AMPK, AMP-activated protein kinase; BA, bempedoic acid; HMGCR, 3-hydroxy-3-methylglutaryl-CoA reductase; ICAM-1, intercellular adhesion molecule-1; LDL-C, low-density lipoprotein cholesterol; MAPK, mitogen-activated protein kinase; NF-kB, nuclear factor kappa B; PCSK9, proprotein convertase subtilisin/kexin type 9; PCSK9 i, proprotein convertase subtilisin/kexin type 9 inhibitor; PXR, pregnane X receptor; TLR, toll-like receptors; TNF-α, tumor necrosis factor-alpha; VCAM-1, vascular cell adhesion molecule-1; VEGF-A, vascular endothelial growth factor A. Created with www.BioRender.com. (assessed on 14 July 2024)
Publication
The Pleiotropic Effects of Lipid-Modifying Interventions: Exploring Traditional and Emerging Hypolipidemic Therapies (2024) Dimitris Kounatidis, et al. Metabolites. 2024 Jul;14(7). Figure: F1.| Organism | Group | Word | Match | Source | NCBI Symbol | NCBI ID |
|---|---|---|---|---|---|---|
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR1 | 7096 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR2 | 7097 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR3 | 7098 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR4 | 7099 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR5 | 7100 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR6 | 10333 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR7 | 51284 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR8 | 51311 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR9 | 54106 |
| Homo sapiens | Primates | TLR | TLR | famplex_relations | TLR10 | 81793 |
| Homo sapiens | Primates | NLRP3 | NLRP3 | ncbigene_symbol | NLRP3 | 114548 |
| Homo sapiens | Primates | HMGCR | HMGCR | ncbigene_symbol | HMGCR | 3156 |
| Homo sapiens | Primates | NF-kB | NF-KB | ncbigene_synonym | NFKB1 | 4790 |
| Homo sapiens | Primates | STOP | STOP | ncbigene_synonym | MAP6 | 4135 |
| Homo sapiens | Primates | PXR | PXR | ncbigene_synonym | NR1I2 | 8856 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP1 | 834 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP2 | 835 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP4 | 837 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP5 | 838 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP6 | 839 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP8 | 841 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP9 | 842 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP10 | 843 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP12 | 100506742 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP14 | 23581 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP3 | 836 |
| Homo sapiens | Primates | Caspase | CASPASE | famplex_relations | CASP7 | 840 |
| Homo sapiens | Primates | VCAM-1 | VCAM1 | ncbigene_symbol | VCAM1 | 7412 |
| Homo sapiens | Primates | TNF-a | TNF-A | ncbigene_synonym | TNF | 7124 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAA1 | 5562 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAA2 | 5563 |
| Homo sapiens | Primates | AMPK | AMPK | ncbigene_synonym | PRKAB1 | 5564 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAB2 | 5565 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG1 | 5571 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG2 | 51422 |
| Homo sapiens | Primates | AMPK | AMPK | famplex_relations | PRKAG3 | 53632 |
| Homo sapiens | Primates | IL-1, | IL-1 | ncbigene_synonym | IL1B | 3553 |
| Homo sapiens | Primates | IL-6, | IL-6 | ncbigene_synonym | IL6 | 3569 |
| Homo sapiens | Primates | ACLY | ACLY | ncbigene_symbol | ACLY | 47 |
| Homo sapiens | Primates | ICAM-1 | ICAM1 | ncbigene_symbol | ICAM1 | 3383 |
| Homo sapiens | Primates | MAPK) | MAPK | famplex_relations | MAPK1 | 5594 |
| Homo sapiens | Primates | MAPK) | MAPK | famplex_relations | MAPK3 | 5595 |
| Homo sapiens | Primates | MAPK) | MAPK | famplex_relations | MAPK11 | 5600 |
| Homo sapiens | Primates | MAPK) | MAPK | famplex_relations | MAPK12 | 6300 |
| Homo sapiens | Primates | MAPK) | MAPK | famplex_relations | MAPK13 | 5603 |
| Homo sapiens | Primates | MAPK) | MAPK | famplex_relations | MAPK14 | 1432 |
| Homo sapiens | Primates | MAPK) | MAPK | famplex_relations | MAPK8 | 5599 |
| Homo sapiens | Primates | MAPK) | MAPK | famplex_relations | MAPK9 | 5601 |
| Homo sapiens | Primates | MAPK) | MAPK | famplex_relations | MAPK10 | 5602 |
| Homo sapiens | Primates | PCSK9 | PCSK9 | ncbigene_symbol | PCSK9 | 255738 |
| Homo sapiens | Primates | VEGF-A | VEGFA | ncbigene_symbol | VEGFA | 7422 |
| Word | Match | MeSH | Name | ChEBI |
|---|---|---|---|---|
| TNF-a | TNF-a | chebi:197439 | ||
| TNF-a | TNF-a | chebi:197439 | ||
| PGE2 | PGE2 | (5Z,13E,15S)-11alpha,15-dihydroxy-9-oxoprosta-5,13-dien-1-oic acid | chebi:15551 |
Disease mentions
| Word | Match | MeSH | Name | DOID |
|---|